Form 4: Roivant Sciences CEO Matthew Gline Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Roivant Sciences CEO Matthew Gline disposed of 10,945 common shares on March 20, 2024, to cover tax withholding obligations related to the vesting and settlement of RSUs.
Summary
- On March 20, 2024, Matthew Gline, CEO of Roivant Sciences Ltd., disposed of 10,945 common shares.
- The transaction was executed to satisfy tax withholding obligations associated with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- The shares were disposed of at a price of $10.01 per share.
- Following the transaction, Gline directly owns 990,063 common shares of Roivant Sciences Ltd.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (disposal of shares for tax obligations) and does not indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders and officers, providing transparency into their transactions involving the company's securities. Disposals to cover tax obligations are common.
Key Dates
| Date | Description |
|---|---|
| 03/20/2024 | Date of transaction: Matthew Gline disposed of 10,945 common shares. |
| 03/22/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.